Technical Data
19 Nov 2024

Pharco Product List

PDF 787 kB
Download

Pharco Pharmaceuticals is a leading manufacturer of high-quality pharmaceuticals, offering a diverse range of products across various therapeutic categories. Our comprehensive portfolio includes:

  • Prescription Medications: Covering a wide array of therapeutic areas, including cardiology, oncology, and infectious diseases.
  • Over-the-Counter (OTC) Products: A selection of non-prescription medications designed to address common health concerns.
  • Biologics and Biosimilars: Innovative treatments that leverage biological processes to provide effective solutions for complex medical conditions.
  • Generic Medications: Affordable alternatives to branded drugs, ensuring accessibility for patients without compromising quality.
  • Dosage Forms: Available in multiple forms, including tablets, capsules, injectables, and topical formulations, to meet diverse patient needs

Content provided by our supplier

Pharco International Company

  • SA
  • 2024
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

Other Content from Pharco International Company (2)

  • News Pharco is leading the Egyptian market with 7.8% share (IQVIA MAT Mar 2024)

    Pharco Pharmaceuticals has established itself as a leader in the Egyptian pharmaceutical market, holding a 7.8% market share. This significant position reflects the company’s commitment to providing high-quality medications across various therapeutic areas. Pharco's success is driven by its extensive product portfolio, innovative manufacturing practices, and dedication to meeting the healthcare needs of the community. As a key player in the industry, Pharco continues to enhance its presence and influence within the Egyptian healthcare sector.
    19 Nov 2024

  • News Forbes' Top 100 Healthcare Leaders in the Middle East!, Dr. Sherine Helmy, CEO of Pharco Pharmaceuticals

    Dr. Sherine Helmy, CEO of Pharco Pharmaceuticals, has been named one of Forbes' Top 100 Healthcare Leaders in the Middle East. This recognition highlights her exceptional leadership and commitment to improving healthcare access in the region. Under her guidance, Pharco has expanded its product portfolio and established advanced manufacturing facilities, reinforcing its position in the pharmaceutical industry. Dr. Helmy's innovative strategies and advocacy for health initiatives have significantly enhanced patient outcomes. This accolade underscores her impactful contributions to the healthcare sector and her dedication to fostering a healthier future. Congratulations to Dr. Helmy on this prestigious honor!
    19 Nov 2024